Horizon Therapeutics (formerly known as Horizon Pharma) is a biopharmaceutical company focused on researching, developing, and commercializing medicines.
Alnylam is a biopharmaceutical company that develops ribonucleic acid interference (RNAi) therapeutics for hepatic porphyria, primary hyperoxaluria type 1 (PH1), cardiovascular, and polyneuropathy treatments.
United Therapeutics is a biotechnology company that develops and manufactures pharmaceutical products for pulmonary arterial hypertension and certain cancers.
Surgery Partners is a healthcare solutions company specializing in managing, developing and acquiring single and multi-specialty ambulatory surgical centers.